Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Global Biologics Market 2018-2022: Size, Trends & Forecasts - Raising Autoimmune Disease Prevalence is One of Many Drivers -

Research and Markets
Posted on: 16 Feb 18

The "Global Biologics Market: Size, Trends & Forecast (2018-2022)" report has been added to's offering.

The global biologics market has increased over the years and projections are made that the market would grow at a steady pace in the next four years i.e. 2018-2022, particularly due to increasing biologics approval and growing incidence of chronic conditions among the aging population.

The global biologics market is supported by various growth drivers such as increased availability of advanced diagnostics, raising auto-immune diseases, higher usage of monoclonal antibodies for the treatment of different diseases, advancement in healthcare & biotechnology, etc. Yet the market faces some challenges which are obstructing the growth of the market. Some of the major challenges faced by the industry are: high cost of biologics, lack of oral absorption, complex regulatory approval etc.

The report provides an in-depth analysis of the global biologics market with description of market sizing and growth. The analysis includes market by value, by segment and by region. It also provides a detailed analysis of biologics market in terms of manufacturing process, product-category and therapeutic areas as well.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global biologics market has also been forecasted for the years 2018-2022, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Market Dynamics

Growth Drivers

  • Increasing Biologics Approvals
  • Raising Autoimmune Disease Prevalence
  • Growing Number of Biosimilars
  • Preference of Biologics over Small Molecules


  • High Cost
  • Lack of Oral Absorption
  • Operational and Technological Challenges
  • Complex Regulatory Approval

Market Trends

  • Increasing Focus on New Therapeutic Areas
  • Potential Biologics Blockbusters
  • Advancement in Healthcare and Biotechnology
  • Commercial Success of Biotech Products
  • Reimbursement Policy

Key Topics Covered:

1. Executive Summary

2. Introduction

3. Global Market Analysis

4. Regional Analysis

5. Market Dynamics

6. Competitive Landscape

7. Company Profiles

  • Abbvie Inc.
  • Amgen Inc.
  • F. Hoffmann La Roche
  • Samsung Electronics (Samsung Biologics)

For more information about this report visit

View source version on

Business Wire

Last updated on: 16/02/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.